Alpine Associates Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Alpine Associates Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,344,094	Closed	-$36.9M	–	62
2022 Q2	$36.9M	Buy	2,344,094 +201,300	+9%	+$3.07M	1.39%	27
2022 Q1	$32.6M	Buy	2,142,794 +15,387	+0.7%	+$234K	1.4%	26
2021 Q4	$32.7M	Buy	+2,127,407	New	+$28M	1.22%	20

Other funds holding NPTN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Alpine Associates Management's NPTN Position: Q3 2022 in Review

Alpine Associates Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 2,344,094 shares — an estimated $36.9M sold.

Alpine Associates Management first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $36.9M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

Alpine Associates Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
Alpine Associates Management sold 2,344,094 NEOPHOTONICS CORP shares in Q3 2022, an estimated $36.9M.
Alpine Associates Management first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
Alpine Associates Management's NEOPHOTONICS CORP position peaked at $36.9M in Q2 2022.
2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Alpine Associates Management's 13F filing for Q3 2022, filed 10 Nov 2022.